Lycia Therapeutics Overview
- Year Founded
-
2019
- Status
-
Public
- Employees
-
31
- Stock Symbol
-
LYCA
- Share Price
-
$33.23
- (As of Friday Closing)
Lycia Therapeutics General Information
Description
Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.
Contact Information
Website
www.lyciatx.comCorporate Office
- 400 East Jamie Court
- Suite 200
- South San Francisco, CA 94080
- United States
Corporate Office
- 400 East Jamie Court
- Suite 200
- South San Francisco, CA 94080
- United States
Lycia Therapeutics Timeline
Lycia Therapeutics Stock Performance
As of 20-Nov-2026, Lycia Therapeutics’s stock price is $33.23. Its current market cap is $1.72B with 52.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $33.23 | $31.77 | $22.19 - $36.49 | $1.72B | 52.1M | 433K | -$1.04 |
Lycia Therapeutics Financials Summary
As of 30-Jun-2026, Lycia Therapeutics has a trailing 12-month revenue of $4.43M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 |
|---|---|---|---|
| Revenue | 4,435 | 6,741 | 14,936 |
| EBITDA | (33,006) | (40,318) | (31,474) |
| Net Income | (30,032) | (36,460) | (26,503) |
| Total Assets | 156,760 | 97,215 | 150,911 |
| Total Debt | 3,162 | 2,749 | 4,771 |
Lycia Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lycia Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Lycia Therapeutics Comparisons
Industry
Financing
Details
Lycia Therapeutics Competitors (7)
One of Lycia Therapeutics’s 7 competitors is Arvinas, a Formerly VC-backed company based in New Haven, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Arvinas | Formerly VC-backed | New Haven, CT | ||||
| Kyverna | Formerly VC-backed | Emeryville, CA | ||||
| Kymera Therapeutics | Formerly VC-backed | Watertown, MA | ||||
| Equillium | Formerly VC-backed | La Jolla, CA | ||||
| Palleon Pharmaceuticals | Venture Capital-Backed | Waltham, MA |
Lycia Therapeutics Patents
Lycia Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026236399-A1 | Anti-transferrin receptor antibodies | Pending | 07-May-2025 | ||
| WO-2026015652-A2 | Anti-ige antibodies with ph-dependent binding characteristics | Pending | 10-Jul-2024 | ||
| WO-2026015652-A3 | Anti-ige antibodies with ph-dependent binding characteristics | Pending | 10-Jul-2024 | ||
| WO-2026015664-A1 | Cycling lysosomal targeting chimeras targeting immunoglobulin e (ige) | Pending | 10-Jul-2024 | ||
| AU-2025245050-A1 | Lysosomal targeting bifunctional molecules for degradation of thyroid stimulating hormone receptor autoantibodies | Pending | 28-Mar-2024 | A61K47/549 |
Lycia Therapeutics Signals
Lycia Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Lycia Therapeutics FAQs
-
When was Lycia Therapeutics founded?
Lycia Therapeutics was founded in 2019.
-
Where is Lycia Therapeutics headquartered?
Lycia Therapeutics is headquartered in South San Francisco, CA.
-
What is the size of Lycia Therapeutics?
Lycia Therapeutics has 31 total employees.
-
What industry is Lycia Therapeutics in?
Lycia Therapeutics’s primary industry is Drug Discovery.
-
Is Lycia Therapeutics a private or public company?
Lycia Therapeutics is a Public company.
-
What is Lycia Therapeutics’s stock symbol?
The ticker symbol for Lycia Therapeutics is LYCA.
-
What is the current stock price of Lycia Therapeutics?
As of 20-Nov-2026 the stock price of Lycia Therapeutics is $33.23.
-
What is the current market cap of Lycia Therapeutics?
The current market capitalization of Lycia Therapeutics is $1.72B.
-
What is Lycia Therapeutics’s current revenue?
The trailing twelve month revenue for Lycia Therapeutics is $4.43M.
-
Who are Lycia Therapeutics’s competitors?
Arvinas, Kyverna, Kymera Therapeutics, Equillium, and Palleon Pharmaceuticals are some of the 7 competitors of Lycia Therapeutics.
-
What is Lycia Therapeutics’s annual earnings per share (EPS)?
Lycia Therapeutics’s EPS for 12 months was -$1.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process